Simultaneous Skin Rejuvenation in Patients Undergoing Medical Treatment for Actinic Keratosis and Non-Melanoma Skin Cancer: A Case Series Analysis

This original article presents the findings of a comprehensive case series, shedding light on the efficacy of diverse treatment modalities for managing precancerous and cancerous skin lesions and their remarkable rejuvenation effects on the skin. A particular focus is placed on the promising outcome...

Full description

Bibliographic Details
Main Authors: Nadia Sciamarrelli, François Rosset, Sara Boskovic, Silvia Borriello, Luca Mastorino, Simone Ribero, Pietro Quaglino, Paolo Broganelli
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cosmetics
Subjects:
Online Access:https://www.mdpi.com/2079-9284/11/1/3
_version_ 1797298574542766080
author Nadia Sciamarrelli
François Rosset
Sara Boskovic
Silvia Borriello
Luca Mastorino
Simone Ribero
Pietro Quaglino
Paolo Broganelli
author_facet Nadia Sciamarrelli
François Rosset
Sara Boskovic
Silvia Borriello
Luca Mastorino
Simone Ribero
Pietro Quaglino
Paolo Broganelli
author_sort Nadia Sciamarrelli
collection DOAJ
description This original article presents the findings of a comprehensive case series, shedding light on the efficacy of diverse treatment modalities for managing precancerous and cancerous skin lesions and their remarkable rejuvenation effects on the skin. A particular focus is placed on the promising outcomes achieved through the application of a combination treatment involving 5-Fluorouracil (5-FU) and salicylic acid, which demonstrates enduring and noteworthy results. Furthermore, alternative therapeutic approaches, including 5-FU monotherapy, Methyl aminolevulinate–photodynamic therapy (MAL-PDT), and the combination of Imiquimod therapy with MAL-PDT, exhibit substantial potential for patients seeking non-surgical solutions. These treatments manifest as valuable tools in improving skin texture and mitigating the effects of photodamage. Nevertheless, the intricate interplay between the chosen treatment, the extent of photodamage, and individual patient characteristics, with a particular emphasis on age, necessitates long-term follow-up to gauge treatment outcomes and the likelihood of lesion recurrence. Notably, these treatments are associated with a significant degree of inflammation, igniting curiosity regarding enhanced skin cellular turnover and the potential for a more youthful skin appearance. Our findings accentuate the promise of topical fluorouracil (5-FU) and photodynamic therapy (PDT) in combating photoaging among patients with actinic keratoses. However, a need for further in-depth research is evident to unravel the nuanced relationships between these treatments, the severity of photodamage, and the influence of patient-specific factors. Such comprehensive investigations are instrumental in optimizing patient care and outcomes, offering a holistic approach to managing photodamage within the context of actinic keratoses. This work, when combined with existing literature, provides valuable insights and serves as a catalyst for future research to fully unlock the potential of these treatments, ultimately enhancing the quality of patient care.
first_indexed 2024-03-07T22:36:47Z
format Article
id doaj.art-b2318e64f47d45579ec9c4dfb2606b8b
institution Directory Open Access Journal
issn 2079-9284
language English
last_indexed 2024-03-07T22:36:47Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Cosmetics
spelling doaj.art-b2318e64f47d45579ec9c4dfb2606b8b2024-02-23T15:12:58ZengMDPI AGCosmetics2079-92842023-12-01111310.3390/cosmetics11010003Simultaneous Skin Rejuvenation in Patients Undergoing Medical Treatment for Actinic Keratosis and Non-Melanoma Skin Cancer: A Case Series AnalysisNadia Sciamarrelli0François Rosset1Sara Boskovic2Silvia Borriello3Luca Mastorino4Simone Ribero5Pietro Quaglino6Paolo Broganelli7Department of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, ItalyDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, ItalyDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, ItalyDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, ItalyDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, ItalyDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, ItalyDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, ItalyDepartment of Medical Sciences, Section of Dermatology, University of Turin, 10126 Turin, ItalyThis original article presents the findings of a comprehensive case series, shedding light on the efficacy of diverse treatment modalities for managing precancerous and cancerous skin lesions and their remarkable rejuvenation effects on the skin. A particular focus is placed on the promising outcomes achieved through the application of a combination treatment involving 5-Fluorouracil (5-FU) and salicylic acid, which demonstrates enduring and noteworthy results. Furthermore, alternative therapeutic approaches, including 5-FU monotherapy, Methyl aminolevulinate–photodynamic therapy (MAL-PDT), and the combination of Imiquimod therapy with MAL-PDT, exhibit substantial potential for patients seeking non-surgical solutions. These treatments manifest as valuable tools in improving skin texture and mitigating the effects of photodamage. Nevertheless, the intricate interplay between the chosen treatment, the extent of photodamage, and individual patient characteristics, with a particular emphasis on age, necessitates long-term follow-up to gauge treatment outcomes and the likelihood of lesion recurrence. Notably, these treatments are associated with a significant degree of inflammation, igniting curiosity regarding enhanced skin cellular turnover and the potential for a more youthful skin appearance. Our findings accentuate the promise of topical fluorouracil (5-FU) and photodynamic therapy (PDT) in combating photoaging among patients with actinic keratoses. However, a need for further in-depth research is evident to unravel the nuanced relationships between these treatments, the severity of photodamage, and the influence of patient-specific factors. Such comprehensive investigations are instrumental in optimizing patient care and outcomes, offering a holistic approach to managing photodamage within the context of actinic keratoses. This work, when combined with existing literature, provides valuable insights and serves as a catalyst for future research to fully unlock the potential of these treatments, ultimately enhancing the quality of patient care.https://www.mdpi.com/2079-9284/11/1/3skin rejuvenationactinic keratosisNMSC5-fluorouracilMAL-PDT
spellingShingle Nadia Sciamarrelli
François Rosset
Sara Boskovic
Silvia Borriello
Luca Mastorino
Simone Ribero
Pietro Quaglino
Paolo Broganelli
Simultaneous Skin Rejuvenation in Patients Undergoing Medical Treatment for Actinic Keratosis and Non-Melanoma Skin Cancer: A Case Series Analysis
Cosmetics
skin rejuvenation
actinic keratosis
NMSC
5-fluorouracil
MAL-PDT
title Simultaneous Skin Rejuvenation in Patients Undergoing Medical Treatment for Actinic Keratosis and Non-Melanoma Skin Cancer: A Case Series Analysis
title_full Simultaneous Skin Rejuvenation in Patients Undergoing Medical Treatment for Actinic Keratosis and Non-Melanoma Skin Cancer: A Case Series Analysis
title_fullStr Simultaneous Skin Rejuvenation in Patients Undergoing Medical Treatment for Actinic Keratosis and Non-Melanoma Skin Cancer: A Case Series Analysis
title_full_unstemmed Simultaneous Skin Rejuvenation in Patients Undergoing Medical Treatment for Actinic Keratosis and Non-Melanoma Skin Cancer: A Case Series Analysis
title_short Simultaneous Skin Rejuvenation in Patients Undergoing Medical Treatment for Actinic Keratosis and Non-Melanoma Skin Cancer: A Case Series Analysis
title_sort simultaneous skin rejuvenation in patients undergoing medical treatment for actinic keratosis and non melanoma skin cancer a case series analysis
topic skin rejuvenation
actinic keratosis
NMSC
5-fluorouracil
MAL-PDT
url https://www.mdpi.com/2079-9284/11/1/3
work_keys_str_mv AT nadiasciamarrelli simultaneousskinrejuvenationinpatientsundergoingmedicaltreatmentforactinickeratosisandnonmelanomaskincanceracaseseriesanalysis
AT francoisrosset simultaneousskinrejuvenationinpatientsundergoingmedicaltreatmentforactinickeratosisandnonmelanomaskincanceracaseseriesanalysis
AT saraboskovic simultaneousskinrejuvenationinpatientsundergoingmedicaltreatmentforactinickeratosisandnonmelanomaskincanceracaseseriesanalysis
AT silviaborriello simultaneousskinrejuvenationinpatientsundergoingmedicaltreatmentforactinickeratosisandnonmelanomaskincanceracaseseriesanalysis
AT lucamastorino simultaneousskinrejuvenationinpatientsundergoingmedicaltreatmentforactinickeratosisandnonmelanomaskincanceracaseseriesanalysis
AT simoneribero simultaneousskinrejuvenationinpatientsundergoingmedicaltreatmentforactinickeratosisandnonmelanomaskincanceracaseseriesanalysis
AT pietroquaglino simultaneousskinrejuvenationinpatientsundergoingmedicaltreatmentforactinickeratosisandnonmelanomaskincanceracaseseriesanalysis
AT paolobroganelli simultaneousskinrejuvenationinpatientsundergoingmedicaltreatmentforactinickeratosisandnonmelanomaskincanceracaseseriesanalysis